Eckert and Ziegler

Eckert & Ziegler SE (Xetra/Frankfurt: EUZ) is a German isotope-technology company headquartered in Berlin, founded in 1992. While not a rare-earth miner, it is a key downstream supplier of radioisotopes and radiopharmaceutical components relevant to critical-minerals and nuclear-medicine supply chains. The company operates through three segments: Medical (radiopharma), Isotope Products and a radiation-therapy business, producing sealed and unsealed radiation sources, therapeutic isotopes such as actinium-225 and lutetium-177, and calibration, industrial-gauging and environmental-monitoring sources. Eckert & Ziegler serves cancer-therapy, molecular-imaging, industrial-radiometry and scientific markets globally through subsidiaries including Eckert & Ziegler BEBIG. Listed on the Frankfurt Stock Exchange with a market capitalization near EUR 1 billion, the company has expanded radiopharmaceutical supply partnerships, including agreements to supply therapeutic radioisotopes to clinical-stage radiopharma developers, reinforcing its role in the global isotope and advanced-materials value chain.